HCAT
NASDAQHealth Catalyst Inc
News · 26 weeks50-17%
2026-03-012026-08-23
Mix2590d
- Insider10(40%)
- SEC Filings6(24%)
- Other6(24%)
- Earnings2(8%)
- Analyst1(4%)
Latest news
25 items- ANALYSTHealth Catalyst downgraded by Canaccord Genuity with a new price targetCanaccord Genuity downgraded Health Catalyst from Buy to Hold and set a new price target of $1.80
- SECSEC Form 10-Q filed by Health Catalyst Inc10-Q - Health Catalyst, Inc. (0001636422) (Filer)
- SECHealth Catalyst Inc filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Health Catalyst, Inc. (0001636422) (Filer)
- PRHealth Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence CompanyCompany retires all credit facility debt; transaction reflects concentrating its technology on improving health system performance.SALT LAKE CITY, Aug. 6, 2026 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst", or the ", Company, ", NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced it closed the sale of Vitalware, LLC, through which the Company conducted its Vitalware business, to Med-Metrix, LLC, a technology-enabled revenue cycle management company, on July 31, 2026. Having used the net cash proceeds plus cash on hand to fully repay and terminate all of its obligations under its credit facility, Healt
- PRHealth Catalyst Reports Second Quarter 2026 ResultsSALT LAKE CITY, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended June 30, 2026. "We delivered a very productive second quarter, exceeding the high end of our revenue guidance and the midpoint of our adjusted EBITDA guidance," said Ben Albert, Chief Executive Officer of Health Catalyst. "More importantly, we recently closed the Vitalware divestiture and fully repaid our credit facility debt, which significantly improves our balance sheet and provides flexibility to make measured near-term bets i
- PRHealth Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026SALT LAKE CITY, July 28, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst", NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its second quarter 2026 operating results on Thursday, August 6, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-274-8461 for U.S. participants, or 203-518-9814 for international participants, and referencing conference ID "HCATQ226." A live audio webcast will be available online at https://ir.healthcatalyst.com/
- INSIDERDirector Hoggard Green Jill was granted 80,691 shares, increasing direct ownership by 126% to 144,628 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERDirector Larson-Green Julie was granted 80,691 shares, increasing direct ownership by 85% to 175,335 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERDirector Nelson Steven H was granted 80,691 shares, increasing direct ownership by 52% to 235,499 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERDirector Spencer Justin was granted 80,691 shares, increasing direct ownership by 118% to 149,263 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- SECHealth Catalyst Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Health Catalyst, Inc. (0001636422) (Filer)
- SECSEC Form SCHEDULE 13D filed by Health Catalyst IncSCHEDULE 13D - Health Catalyst, Inc. (0001636422) (Subject)
- PRHealth Catalyst to Participate in Upcoming Investor ConferenceSALT LAKE CITY, June 16, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference, including a panel discussion titled "AI ROI in Healthcare: Real vs Hype Debate," with Ben Albert, Chief Executive Officer, on Wednesday, June 24, 2026, at 3:30pm ET. About Health Catalyst Health Catalyst, Inc. (NASDAQ:HCAT) is a healthcare intelligence company that accelerates measurable improvement for health systems across cost, clinical,
- INSIDERCEO Albert Benjamin covered exercise/tax liability with 34,485 shares, decreasing direct ownership by 2% to 1,423,971 units (SEC Form 4) (for tax liability)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Health Catalyst IncSCHEDULE 13D/A - Health Catalyst, Inc. (0001636422) (Subject)
- PRMed-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue YieldPARSIPPANY, N.J., June 4, 2026 /PRNewswire/ -- Med-Metrix, LLC ("Med-Metrix"), backed by Harvest Partners and A&M Capital Partners, today announced it has entered into a definitive agreement to acquire Vitalware, an industry-leading revenue workflow and analytics software business owned by Health Catalyst (NASDAQ:HCAT). Vitalware's platform and domain expertise will strengthen Med-Metrix's mid-revenue cycle offering, improving charge capture and coding accuracy, which is expected to help drive measurable improvement in net revenue yield for Med-Metrix's clients. The transaction will augment Med-Metrix's technology-enable
- SECHealth Catalyst Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Health Catalyst, Inc. (0001636422) (Filer)
- PRHealth Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic TransformationSALT LAKE CITY, June 04, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst" or the "Company, NASDAQ:HCAT) today announced it has signed a definitive agreement to divest Vitalware, LLC and the Vitalware business unit, its mid-revenue cycle business, to Med-Metrix for a total consideration of $147 million in cash. This divestiture sharpens Health Catalyst's focus on driving measurable improvement for health systems across cost, clinical, and consumer performance, and the Company expects it to accelerate the broader transformation underway. "This is a big step forward for Health Catalyst. We are concentrating our business around the areas where we have the deepest conviction,
- INSIDERCEO Albert Benjamin covered exercise/tax liability with 336 shares, decreasing direct ownership by 0.02% to 1,458,456 units (SEC Form 4) to satisfy withholding obligation4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERChief People Officer Llewelyn Linda covered exercise/tax liability with 8,519 shares, decreasing direct ownership by 3% to 321,132 units (SEC Form 4) to cover taxes4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERChief Financial Officer Alger Jason covered exercise/tax liability with 18,804 shares, decreasing direct ownership by 3% to 722,840 units (SEC Form 4) (for withholding tax)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERGeneral Counsel Landry Benjamin covered exercise/tax liability with 13,779 shares, decreasing direct ownership by 4% to 364,539 units (SEC Form 4) (tax liability)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- INSIDERDirector Larson-Green Julie was granted 12,710 shares, increasing direct ownership by 16% to 94,644 units (SEC Form 4)4 - Health Catalyst, Inc. (0001636422) (Issuer)
- SECSEC Form DEFA14A filed by Health Catalyst IncDEFA14A - Health Catalyst, Inc. (0001636422) (Filer)
- SECSEC Form DEF 14A filed by Health Catalyst IncDEF 14A - Health Catalyst, Inc. (0001636422) (Filer)
HCAT FAQ
7 questionsWhat does Health Catalyst Inc do?
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its solutions include a cloud-based data platform, analytics software, and professional services. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. The company was founded in 2008 and is headquartered in South Jordan, Utah.Where does HCAT stock trade?
Health Catalyst Inc (HCAT) is listed on NASDAQ.What sector and industry is HCAT in?
Health Catalyst Inc operates in the Technology sector, Computer Software: Programming Data Processing industry.When did Health Catalyst Inc go public?
Health Catalyst Inc (HCAT) completed its IPO in 2019.What are analysts saying about HCAT?
Health Catalyst Inc has had 8 recent analyst actions on file. The most recent action was from Canaccord Genuity: Hold with a $180.00 price target on 2026-08-21.What companies are similar to HCAT?
Notable peers in the same industry include GOOGL (Alphabet Inc.), GOOG (Alphabet Inc.), META (Meta Platforms Inc.), APP (Applovin Corporation), NBIS (Nebius Group N.V.). Compare HCAT side-by-side with any of them on Quantisnow.How can I track HCAT on Quantisnow?
Quantisnow aggregates Health Catalyst Inc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HCAT to receive live email and push alerts on every new disclosure.